Vascular endothelial growth factor mRNA and its protein expression in decidua after terminating early pregnancy by mifepristone plus misoprostol
10.3760/j.issn:0366-6999.2001.05.018
- VernacularTitle:米非司酮抗早孕出血副反应机理研究——蜕膜血管内皮细胞生长因子mRNA及蛋白表达观察
- Author:
HUANGLili
1
;
Yifu SHI
Author Information
1. 浙江大学附属妇产科医院
- From:
Chinese Medical Journal
2001;114(5):517-519
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the action of mifepristone plus misoprostol on decidua at the level of vascular endothelial growth factor (VEGF) mRNA and its protein expression, as well as the mechanism of prolonged uterine hemorrhage after terminating early pregnancy with these drugs.Methods Forty-five decidua specimens were obtained from 45 pregnant women with amenorrhea of 6 - 7 weeks' duration, in which 15 women were treated with mifepristone and 15 were given mifepristone plus misoprostol. Enzyme-linked immunosorbant assay (ELISA) and reverse transcription-polymerase chain reaction (RT-PCR) were used to detect VEGF protein and mRNA levels in decidua.Results In all three groups, only the VEGF121 amplification product of 452 bp was visualized. The mRNA and protein levels of VEGF showed no significant differences among the three groups ( P ＞ 0.05).Conclusion In humans, early decidua VEGF121 mRNA is the main isoform. The action of mifepristone plus misoprostol on blood vessels in human decidua may be medicated by some factors other than VEGF.
